News
Paris: Sanofi has received orphan drug designation from the US Food and Drug Administration (FDA) for rilzabrutinib, a novel, ...
Rilzabrutinib granted orphan drug designation in the US for sickle cell disease <li /> Fourth orphan drug designation for rilzabrutinib ...
Although the world has largely moved on from Covid-19, a lot of trust was destroyed including – unfortunately and worryingly ...
Over 13 years after cloning Noori, SKUAST scientists engineered India’s first gene-edited sheep, marking a rare scientific ...
Kashmir University Scientists Pioneer India's First CRISPR-Edited Sheep - SKUAST-Kashmir scientists developed Indias first ...
2h
News-Medical.Net on MSNScientists explain how eating a rainbow of foods lowers your risk for chronic illnessConsuming a variety of flavonoid-rich foods can lower all-cause mortality and chronic disease risks, emphasizing the ...
10h
Zacks.com on MSNSNY's Rilzabrutinib Wins 4th Orphan Drug Tag for Sickle Cell DiseaseSanofi's rilzabrutinib earns its fourth orphan drug status from the FDA, this time targeting sickle cell disease.
With every 100 grams of ultra-processed foods you consume each day, your risk of developing cardiovascular disease, hypertension, digestive diseases, and cancer increases.
Sanofi announced today that the U.S. FDA has granted orphan drug designation to rilzabrutinib for the treatment of sickle ...
California is moving forward to pass the first state law to define potentially harmful ultraprocessed foods and prohibit them from being added to school lunches.
Researchers at Colorado State University have developed a tool that can be used to switch a plant's key genetic traits on or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results